Coronavirus Outbreak: US president Donald Trump and Anthony Fauci see hope in Gilead's drug Remdesivir

Dr Anthony Fauci, though, told reporters during a White House meeting with Donald Trump that the data on the drug, Remdesivir, needs to be further analysed.

|Apr 30, 2020, 07:45:04 IST

Washington: US president Donald Trump on Wednesday greeted as good news reports that a Gilead Sciences Inc experimental antiviral drug might help fight the coronavirus, and infectious disease official Anthony Fauci said data shows it appears to help patients hospitalized with COVID-19.[caption id="attachment_8213531" align="alignleft" width="380"] Dr Anthony Fauci and members of the coronavirus task force attend President Donald Trump's briefing on Sunday. By Pete Marovich © 2020 The New York Times[/caption]Fauci, though, told reporters during a White House meeting with Trump that the data on the drug, Remdesivir, needs to be further analysed.Some trial data for the drug will likely be announced later on Wednesday at a White House task force briefing, according to the National Institute of Allergy and Infectious Diseases.Gilead on Wednesday said Remdesivir helped improve outcomes for patients with COVID-19 in a clinical trial, and provided data suggesting it worked better when given earlier in the course of illness caused by the virus. The closely watched drug has moved markets in the past few weeks following release of partial information on several studies that painted a mixed picture of its effectiveness.Former US Food and Drug Administration chief Scott Gottlieb said on Twitter there was now enough data to support authorising the drug for emergency use.Fauci told reporters the data shows the drug had benefit in reducing the time to recover from the virus. While the data still must be peer-reviewed, he said it is opening the door to the possibility of a treatment.There are currently no approved treatments or vaccines for the highly contagious novel coronavirus, but many approaches are being tried while awaiting an effective vaccine to prevent infection by the virus.Trump said it is a beginning that can be built upon.Asked by Fox Business Network earlier if the results announced by Gilead were a positive for the economy, White House economic adviser Larry Kudlow said: “Has to be a tremendous positive.”“These are confidence-inspiring things that will help open the economy and get folks back to work,” he said of any drug trials that show promise.

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.

2 min read

Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key

From boosting metabolism to supporting heart health, chillies offer several surprising health benefits. But experts say the amount you eat matters, and too much spice can do more harm than good.

4 min read

Organ donation: 5 myths you need to stop believing, according to a transplant specialist

Organ donation has the power to transform and save lives, but this can happen only when myths are replaced with facts. Building awareness, having open conversations and understanding the process can help families make informed decisions.

2 min read

Fish over meat: Why a pescatarian diet may help people with obesity live longer

A large UK study tracking over 150,000 adults with clinical obesity found pescatarians outlived regular meat-eaters, while vegetarians and vegans saw no similar benefit, but experts say the findings don't translate simply to Indian diets.